UNSPSC 51142551: Ifenprodil tartrate

This classification denotes a platelet aggregation inhibitor, antiparkinson agent, and anticonvulsant with the molecular formula 2C21H27NO2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 89CTB4XUF7, chemically known as 4-benzyl-1-(beta,4-dihydroxy-alpha-methylphenethyl)piperidinium hydrogen tartrate but more generally known as ifenprodil tartrate, which bears US NIH Compound Identifier 134832.

UNSPSC 51142551 Ifenprodil tartrate is a Commodity code with minimal alignment to recent state and local procurement activity. The three most recent opportunities tagged to this code—Seminole County's naloxone and drug deactivation systems procurement, the Texas Health and Human Services Commission's therapeutic pharmacy initiative RFI, and the Minnesota Multistate Cooperative Purchasing Alliance's generic pharmaceuticals RFP—do not target ifenprodil tartrate specifically. State and local governments are soliciting broader pharmaceutical categories, including naloxone (an opioid antagonist), generic multi-source drugs through cooperative purchasing vehicles, and direct-to-manufacturer prescription programs, but the source does not identify any active state or local procurement focused on ifenprodil tartrate itself.

The code shows activity from state health agencies and county health departments using cooperative purchasing frameworks and traditional competitive bidding, but the recent opportunities reflect demand for widely available commodities and program-level pharmacy services rather than for this specific pharmaceutical ingredient. Seminole County released IFB 60459723LAS (due July 26, 2023) for naloxone and drug deactivation systems; Texas HHS issued RFI HHS0017013 (response deadline April 3, 2026) to explore direct manufacturer prescription models; and Minnesota's cooperative purchasing vehicle posted RFP S1070000015802 (due March 26, 2026) for generic pharmaceuticals and OTC products across multiple state and local participants including Oregon. The geographic spread across Florida, Texas, and Minnesota reflects regional health agency procurement, but none targets ifenprodil tartrate. Unless your firm manufactures this compound as part of a broader pharmaceutical supply contract or can bundle it within a state's generic drug or direct-prescription program, this code presents limited near-term pursuit opportunity based on current market signals.